真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

穿孔素1(PRF1)多克隆抗體(生物素標記)

Biotin-Linked Polyclonal Antibody to Perforin 1 (PRF1)

FLH2; HPLH2; P1; PFP; Pore Forming Protein; Cytolysin; Lymphocyte pore-forming protein

  • 穿孔素1(PRF1)多克隆抗體(生物素標記) 產品包裝(模擬)
  • 穿孔素1(PRF1)多克隆抗體(生物素標記) 產品包裝(模擬)
  • 穿孔素1(PRF1)多克隆抗體(生物素標記) DAB staining on IHC-P;<br/>Samples: Human Lymph node Tissue; <br/>Primary Ab: 20μg/ml Biotin-Linked Polyclonal Antibody to Perforin 1 (PRF1)<br/>Second Ab: 2μg/ml HRP-Labeled Streptavidin (Catalog: IS089)
  • Certificate 通過ISO 9001、ISO 13485質量體系認證

特異性

該抗體是針對PRF1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別PRF1。

用法

免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學:5-20μg/mL;1:25-100
免疫細胞化學:5-20μg/mL;1:25-100
最佳稀釋倍數最終由用戶決定。

儲存

經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩定性

熱穩定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。

贈品

相關產品

編號 適用物種:Homo sapiens (Human,人) 應用(僅供研究使用,不用于臨床診斷!)
RPB317Hu02 穿孔素1(PRF1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APB317Hu01 穿孔素1(PRF1)活性蛋白 Cell?culture;?Activity?Assays.
RPB317Hu01 穿孔素1(PRF1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APB317Hu02 穿孔素1(PRF1)活性蛋白 Cell?culture;?Activity?Assays.
PAB317Hu01 穿孔素1(PRF1)多克隆抗體 WB; IHC; ICC; IP.
LAB317Hu81 穿孔素1(PRF1)多克隆抗體(異硫氰酸熒光素標記) WB; IHC; ICC; IF.
LAB317Hu71 穿孔素1(PRF1)多克隆抗體(生物素標記) WB; IHC; ICC.
MAB317Hu22 穿孔素1(PRF1)單克隆抗體 WB; IHC; ICC; IP.
MAB317Hu21 穿孔素1(PRF1)單克隆抗體 WB; IHC; ICC; IP.
SEB317Hu 穿孔素1(PRF1)檢測試劑盒(酶聯免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB317Hu 穿孔素1(PRF1)等多因子檢測試劑盒(流式熒光發光法) FLIA Kit for Antigen Detection.

參考文獻

雜志 參考文獻
Diagnostic Microbiology and Infectious Disease Granzyme B as a diagnostic marker of tuberculosis in patients with and without HIV coinfection [Pubmed:26915636]
FASEB?JOURNAL The immunoregulatory effects of CD8 T-cell–derived perforin on diet-induced nonalcoholic steatohepatitis [Pubmed: 30951375]
Theranostics A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors [Pubmed: 31695790]
Mol Immunol CD317 mediates immunocytolysis resistance by RICH2/cytoskeleton-dependent membrane protection [Pubmed: 33223223]
INVESTIGATIONAL NEW DRUGS Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors [Pubmed: 32772342]
Am J Transl Res Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma [34377237]
Nat Biomed Eng Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy [34873307]
J Exp Med Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion [Pubmed:35061012]
留言咨詢
松潘县| 富川| 红原县| 石城县| 汤阴县| 绥棱县| 宣化县| 通州区| 鸡西市| 富平县| 莱州市| 峨山| 平邑县| 于田县| 当涂县| 周至县| 牟定县| 柳河县| 合肥市| 额济纳旗| 平邑县| 武清区| 甘孜| 综艺| 刚察县| 德清县| 福清市| 新建县| 星子县| 大荔县| 牡丹江市| 南阳市| 油尖旺区| 靖边县| 乌鲁木齐县| 两当县| 屏边| 林西县| 东明县| 曲水县| 泸定县|